anti neurexin 1α extracellular atto 488 antibody  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Alomone Labs anti neurexin 1α extracellular atto 488 antibody
    Effect of HSA-28P and HSA-28 on the binding affinity of <t>anti-Neurexin</t> <t>1α</t> antibody INS-1E cells that were seeded in 12-well plates. The cells were incubated with HSA-28P, “naked” nanoparticles or HSA-28 peptide for 24 h. After the indicated incubation time, cells were exposed to ATTO 488-fluorescent labeled antibody against an extracellular epitope of Neurexin 1α according to the manufacturer`s protocol. After then, cells were taken to Gallios Fluorescence Activated Cell Sorter. Control cells (A), treated only by anti-Neurexin 1α antibody ( B ), treated by HSA-28P and anti-Neurexin 1α antibody ( C ), treated by “naked” nanoparticles and anti-Neurexin 1α antibody ( D ) and finally cells treated by HSA-28 and anti-Neurexin 1α antibody ( E ). The summary of the spectra of the fluorescent signals (F). The summary of cell counts and percentage of the inhibition. n=3.
    Anti Neurexin 1α Extracellular Atto 488 Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti neurexin 1α extracellular atto 488 antibody/product/Alomone Labs
    Average 90 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti neurexin 1α extracellular atto 488 antibody - by Bioz Stars, 2022-05
    90/100 stars

    Images

    1) Product Images from "Mimicking Neuroligin-2 Functions in β-cells by Functionalized Nanoparticles as a Novel Approach for Antidiabetic Therapy"

    Article Title: Mimicking Neuroligin-2 Functions in β-cells by Functionalized Nanoparticles as a Novel Approach for Antidiabetic Therapy

    Journal: ACS applied materials & interfaces

    doi: 10.1021/acsami.6b10568

    Effect of HSA-28P and HSA-28 on the binding affinity of anti-Neurexin 1α antibody INS-1E cells that were seeded in 12-well plates. The cells were incubated with HSA-28P, “naked” nanoparticles or HSA-28 peptide for 24 h. After the indicated incubation time, cells were exposed to ATTO 488-fluorescent labeled antibody against an extracellular epitope of Neurexin 1α according to the manufacturer`s protocol. After then, cells were taken to Gallios Fluorescence Activated Cell Sorter. Control cells (A), treated only by anti-Neurexin 1α antibody ( B ), treated by HSA-28P and anti-Neurexin 1α antibody ( C ), treated by “naked” nanoparticles and anti-Neurexin 1α antibody ( D ) and finally cells treated by HSA-28 and anti-Neurexin 1α antibody ( E ). The summary of the spectra of the fluorescent signals (F). The summary of cell counts and percentage of the inhibition. n=3.
    Figure Legend Snippet: Effect of HSA-28P and HSA-28 on the binding affinity of anti-Neurexin 1α antibody INS-1E cells that were seeded in 12-well plates. The cells were incubated with HSA-28P, “naked” nanoparticles or HSA-28 peptide for 24 h. After the indicated incubation time, cells were exposed to ATTO 488-fluorescent labeled antibody against an extracellular epitope of Neurexin 1α according to the manufacturer`s protocol. After then, cells were taken to Gallios Fluorescence Activated Cell Sorter. Control cells (A), treated only by anti-Neurexin 1α antibody ( B ), treated by HSA-28P and anti-Neurexin 1α antibody ( C ), treated by “naked” nanoparticles and anti-Neurexin 1α antibody ( D ) and finally cells treated by HSA-28 and anti-Neurexin 1α antibody ( E ). The summary of the spectra of the fluorescent signals (F). The summary of cell counts and percentage of the inhibition. n=3.

    Techniques Used: Binding Assay, Incubation, Labeling, Fluorescence, Inhibition

    2) Product Images from "Mimicking Neuroligin-2 Functions in β-cells by Functionalized Nanoparticles as a Novel Approach for Antidiabetic Therapy"

    Article Title: Mimicking Neuroligin-2 Functions in β-cells by Functionalized Nanoparticles as a Novel Approach for Antidiabetic Therapy

    Journal: ACS applied materials & interfaces

    doi: 10.1021/acsami.6b10568

    Effect of HSA-28P and HSA-28 on the binding affinity of anti-Neurexin 1α antibody INS-1E cells that were seeded in 12-well plates. The cells were incubated with HSA-28P, “naked” nanoparticles or HSA-28 peptide for 24 h. After the indicated incubation time, cells were exposed to ATTO 488-fluorescent labeled antibody against an extracellular epitope of Neurexin 1α according to the manufacturer`s protocol. After then, cells were taken to Gallios Fluorescence Activated Cell Sorter. Control cells (A), treated only by anti-Neurexin 1α antibody ( B ), treated by HSA-28P and anti-Neurexin 1α antibody ( C ), treated by “naked” nanoparticles and anti-Neurexin 1α antibody ( D ) and finally cells treated by HSA-28 and anti-Neurexin 1α antibody ( E ). The summary of the spectra of the fluorescent signals (F). The summary of cell counts and percentage of the inhibition. n=3.
    Figure Legend Snippet: Effect of HSA-28P and HSA-28 on the binding affinity of anti-Neurexin 1α antibody INS-1E cells that were seeded in 12-well plates. The cells were incubated with HSA-28P, “naked” nanoparticles or HSA-28 peptide for 24 h. After the indicated incubation time, cells were exposed to ATTO 488-fluorescent labeled antibody against an extracellular epitope of Neurexin 1α according to the manufacturer`s protocol. After then, cells were taken to Gallios Fluorescence Activated Cell Sorter. Control cells (A), treated only by anti-Neurexin 1α antibody ( B ), treated by HSA-28P and anti-Neurexin 1α antibody ( C ), treated by “naked” nanoparticles and anti-Neurexin 1α antibody ( D ) and finally cells treated by HSA-28 and anti-Neurexin 1α antibody ( E ). The summary of the spectra of the fluorescent signals (F). The summary of cell counts and percentage of the inhibition. n=3.

    Techniques Used: Binding Assay, Incubation, Labeling, Fluorescence, Inhibition

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90
    Alomone Labs anti neurexin 1α extracellular atto 488 antibody
    Effect of HSA-28P and HSA-28 on the binding affinity of <t>anti-Neurexin</t> <t>1α</t> antibody INS-1E cells that were seeded in 12-well plates. The cells were incubated with HSA-28P, “naked” nanoparticles or HSA-28 peptide for 24 h. After the indicated incubation time, cells were exposed to ATTO 488-fluorescent labeled antibody against an extracellular epitope of Neurexin 1α according to the manufacturer`s protocol. After then, cells were taken to Gallios Fluorescence Activated Cell Sorter. Control cells (A), treated only by anti-Neurexin 1α antibody ( B ), treated by HSA-28P and anti-Neurexin 1α antibody ( C ), treated by “naked” nanoparticles and anti-Neurexin 1α antibody ( D ) and finally cells treated by HSA-28 and anti-Neurexin 1α antibody ( E ). The summary of the spectra of the fluorescent signals (F). The summary of cell counts and percentage of the inhibition. n=3.
    Anti Neurexin 1α Extracellular Atto 488 Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti neurexin 1α extracellular atto 488 antibody/product/Alomone Labs
    Average 90 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti neurexin 1α extracellular atto 488 antibody - by Bioz Stars, 2022-05
    90/100 stars
      Buy from Supplier

    86
    Alomone Labs atto488
    Effect of HSA-28P and HSA-28 on the binding affinity of <t>anti-Neurexin</t> <t>1α</t> antibody INS-1E cells that were seeded in 12-well plates. The cells were incubated with HSA-28P, “naked” nanoparticles or HSA-28 peptide for 24 h. After the indicated incubation time, cells were exposed to ATTO 488-fluorescent labeled antibody against an extracellular epitope of Neurexin 1α according to the manufacturer`s protocol. After then, cells were taken to Gallios Fluorescence Activated Cell Sorter. Control cells (A), treated only by anti-Neurexin 1α antibody ( B ), treated by HSA-28P and anti-Neurexin 1α antibody ( C ), treated by “naked” nanoparticles and anti-Neurexin 1α antibody ( D ) and finally cells treated by HSA-28 and anti-Neurexin 1α antibody ( E ). The summary of the spectra of the fluorescent signals (F). The summary of cell counts and percentage of the inhibition. n=3.
    Atto488, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/atto488/product/Alomone Labs
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    atto488 - by Bioz Stars, 2022-05
    86/100 stars
      Buy from Supplier

    Image Search Results


    Effect of HSA-28P and HSA-28 on the binding affinity of anti-Neurexin 1α antibody INS-1E cells that were seeded in 12-well plates. The cells were incubated with HSA-28P, “naked” nanoparticles or HSA-28 peptide for 24 h. After the indicated incubation time, cells were exposed to ATTO 488-fluorescent labeled antibody against an extracellular epitope of Neurexin 1α according to the manufacturer`s protocol. After then, cells were taken to Gallios Fluorescence Activated Cell Sorter. Control cells (A), treated only by anti-Neurexin 1α antibody ( B ), treated by HSA-28P and anti-Neurexin 1α antibody ( C ), treated by “naked” nanoparticles and anti-Neurexin 1α antibody ( D ) and finally cells treated by HSA-28 and anti-Neurexin 1α antibody ( E ). The summary of the spectra of the fluorescent signals (F). The summary of cell counts and percentage of the inhibition. n=3.

    Journal: ACS applied materials & interfaces

    Article Title: Mimicking Neuroligin-2 Functions in β-cells by Functionalized Nanoparticles as a Novel Approach for Antidiabetic Therapy

    doi: 10.1021/acsami.6b10568

    Figure Lengend Snippet: Effect of HSA-28P and HSA-28 on the binding affinity of anti-Neurexin 1α antibody INS-1E cells that were seeded in 12-well plates. The cells were incubated with HSA-28P, “naked” nanoparticles or HSA-28 peptide for 24 h. After the indicated incubation time, cells were exposed to ATTO 488-fluorescent labeled antibody against an extracellular epitope of Neurexin 1α according to the manufacturer`s protocol. After then, cells were taken to Gallios Fluorescence Activated Cell Sorter. Control cells (A), treated only by anti-Neurexin 1α antibody ( B ), treated by HSA-28P and anti-Neurexin 1α antibody ( C ), treated by “naked” nanoparticles and anti-Neurexin 1α antibody ( D ) and finally cells treated by HSA-28 and anti-Neurexin 1α antibody ( E ). The summary of the spectra of the fluorescent signals (F). The summary of cell counts and percentage of the inhibition. n=3.

    Article Snippet: Anti-Neurexin 1α (extracellular)-ATTO-488 antibody was purchased from (Alomone Labs, Jerusalem, Israel) .

    Techniques: Binding Assay, Incubation, Labeling, Fluorescence, Inhibition